Atla-Alternatives to Laboratory Animals

Papers
(The TQCC of Atla-Alternatives to Laboratory Animals is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The Safety Assessment of Cosmetic Perfumes by Using In Chemico and In Vitro Methods in Combination with GC154
Spotlight on Three Rs Progress46
Spotlight on Three Rs Progress38
The Use of Human Tissues for Research: What Investigators Need to Know26
The Development of an Animal Product-free, Precision-cut Lung Slice Cryopreservation and Post-thaw Culture Method19
Conference Diary18
Combinatorial induction with valproic acid and fibroblast growth factor-9 enhances neural differentiation and cell fate commitment in adipose tissue-derived mesenchymal stem cells17
Evaluation of the antinociceptive effects of gabapentin using Gromphadorhina portentosa as a non-vertebrate in vivo 16
Toxicological Profiling of Potential Shikimate Kinase Inhibitors Against Mycobacterium tuberculosis16
Brazilian National Network of Alternative Methods (RENAMA) 10th Anniversary: Meeting of the Associated Laboratories, May 202213
Development of Sensitive In Vitro Protocols for the Biocompatibility Testing of Medical Devices and Pharmaceuticals Intended for Contact with the Eyes: A12
A History of the Development of Alternatives to Animals in Research and Testing11
Conference Diary11
Progress and Remaining Opportunities to Increase the Use of Animal-free Antibodies in the USA11
Resources Round-up10
Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the Stakeholders10
Resources Round-up9
Editorial9
Dr Manfred Liebsch: Former Head of ZEBET and ATLA Editorial Board Member9
Editorial9
In Silico Prediction of Human Clinical Pharmacokinetics with ANDROMEDA by Prosilico: Predictions for an Established Benchmarking Data Set, a Modern Small Drug Data Set, and 9
Reviewing Current Guidance for the ‘R’ of Replacement and Rethinking it with the ‘Replacement Checklist’8
The impossible made possible through the use of New Approach Methodologies: Dermal safety assessment of potential insect repellent or insecticidal active ingredients using a high-throughput approach t8
Editorial7
Resources Round-up7
2021 Michael Balls Award7
The 19th FRAME Annual Lecture, November 2022: Safer Chemicals and Sustainable Innovation Will Be Achieved by Regulatory Use of Modern Safety Science, Not by More Animal Testing6
Editorial6
Thanks to Reviewers6
Fenugreek Seed Extract Regulates Human Umbilical Vein Endothelial Cell Angiogenesis and Proliferation via the PI3K/Akt/Cyclin D1 Pathway6
Addressing Animal Welfare Issues in Fetal Blood Collection for Fetal Bovine Serum Production6
Spotlight on Three Rs Progress6
A Cytotoxicity Assay as an Alternative to the Murine Model for the Potency Testing of Bothrops jararaca Venom and Antivenom: An Intralaboratory Pre-valid5
The Numbers of Animals Used in Mexico for Scientific and Educational Purposes5
Book Review: Lab dog: A beagle and his human investigate the surprising world of animal research Melanie D.G. Kaplan (2025). Lab Dog: A Beagle and His Human Investigate the Surprising World of Animal 5
Synthetic substrates as alternatives to bovine enamel in restorative dental materials research — A review5
Development of Two Korean IACUC Guidance Documents to Foster Implementation of the Three Rs5
Editorial5
Editorial5
Spotlight on Three Rs Progress5
Corrigendum to Case Studies Exemplifying the Transition to Animal Component-Free Cell Culture5
Resources Round-up4
Spotlight on Three Rs Progress4
Case Studies Exemplifying the Transition to Animal Component-free Cell Culture4
Editorial4
Editorial4
Determining the pathogenicity of uropathogenic Escherichia coli strains in the Galleria mellonella larvae 4
Optimisation of a Method for the Differentiation of Human Umbilical Cord-derived Mesenchymal Stem Cells Toward Renal Epithelial-like Cells4
Human NT2/D1-derived early neural progenitor cells immobilised in alginate microfibres as an in vitro 3D system for neurotoxicity testing4
The Current Status and Work of Three Rs Centres and Platforms in Europe*4
Accelerating Animal Replacement: How Universities Can Lead — Results of a One-Day Expert Workshop in Zurich, Switzerland4
Editorial4
The Use of 3-D Models of Echocardiographic Imaging Planes for Teaching Echocardiography Techniques for Use in Dogs and Cats3
Use of the Allium cepa Model to Assess the Cytogenotoxicity of Luffariella herdmani Marine Sponge Extract3
Introducing the COST Action ‘Improving the Quality of Biomedical Science with 3Rs Concepts’ (IMPROVE)3
Conference Diary3
Transparency in Non-Technical Project Summaries to Promote the Three Rs in Respiratory Disease Research3
Modelling the Sorafenib-resistant Liver Cancer Microenvironment by Using 3-D Spheroids3
Editorial3
Editorial3
Resources Round-up3
Spotlight on Three Rs Progress3
Lessons for the Future of NAMs from History, Philosophy and Social Studies of Science3
The Application of New Approach Methodologies in Respiratory Disease Research: Their Role in Improving Translational Medicine from Bench to Bedside3
0.15240097045898